Mentari Therapeutics, Inc. (MTRI)
NASDAQ · Manufacturing · Pharmaceutical preparations
MTRI price, last 12 months
Key stats
- Previous close
- $15.29
- Open
- $14.90
- Day range
- $13.81 – $15.51
- 52-week range
- $2.88 – $20.00
- Volume
- 21.1K
- Avg volume (20 days)
- 51.3K
- Market cap
- $1.1B
Performance
Technicals and fundamentals
About Mentari Therapeutics, Inc.
Mentari Therapeutics Inc is a biotechnology company engaged in the development of therapies for the prevention of migraine. Its product pipeline includes MT-001, an anti-PACAP monoclonal antibody, and MT-002, a bispecific antibody targeting both CGRP and PACAP pathways. The company's research and development activities focus on therapeutic candidates targeting PACAP and CGRP-related mechanisms for migraine prevention.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.1B